My Dose Coach Mobile App to Support Insulin Titration and Maintenance
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2
Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)
- Status
- TERMINATED
- Phase
- PHASE2
Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
French National Cohort of People With Type 1 Diabetes
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ
- Status
- COMPLETED
- Phase
- PHASE4
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cognitive and Neurological Pathologies in Pompe Disease
- Status
- RECRUITING
- Phase
- N/A
Observational Study of Long-Term Joint Health Outcome in Hemophilia Patient
- Status
- UNKNOWN
- Phase
- N/A
Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE4
Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients
- Status
- TERMINATED
- Phase
- PHASE3
Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3